Ergun Akturk

About Ergun Akturk

Analytical Development Scientist with extensive experience supporting analytical method development, qualification, and transfer for advanced therapeutics, including cell and gene therapies.My work focuses on translating complex analytical methods from development to GMP environments while ensuring assay robustness, regulatory readiness, and cross-functional alignment between Analytical Development, Quality Control, and Manufacturing.Key expertise includes:• Analytical method transfer and lifecycle management• Assay qualification and validation (ICH Q2)• Flow cytometry, ddPCR, qPCR, and potency assays• GMP analytical testing and QC implementation• CMC analytical strategy for IND-enabling programs• Cross-functional collaboration with QC, QA, and CDMOsI have contributed to analytical strategies supporting viral vector and cell therapy programs, ensuring methods are fit-for-purpose from early development through clinical manufacturing.Prior to industry, I conducted academic research on bacteriophage-antibiotic combinations targeting biofilm infections, resulting in peer-reviewed publications in microbiology and biotechnology.I am passionate about bridging scientific innovation with practical GMP implementation to accelerate the development of advanced therapeutics. Based in Boston area

Experience

1. Adjunct Instructor, Rabb School of Continuing Studies, Division of Graduate Professional Studies

   Brandeis University

   Aug 2025 — Present · Waltham, MA, US

   Designed and delivered graduate-level courses on regulatory science, analytical quality control, and advanced immunotherapy, with applications in cell and gene therapy • Developed course content covering analytical validation (ICH Q2), lifecycle management (ICH Q14), and regulatory strategies for IND/BLA submissions • Introduced advanced topics including viral vector technologies (AAV, lentivirus), immunotherapy platforms, and translational research challenges • Mentored students in applying regulatory and scientific principles to real-world biopharmaceutical case studies • Designed structured assignments, case-based discussions, and evaluation frameworks to enhance critical thinking and scientific communication • Contributed to curriculum development aligned with current industry and regulatory expectations

Education

• Ege University

  Master of Science - MS, Medical Microbiology

  2014 — 2015

• Universidade do Minho

  Doctor of Philosophy (PhD), Chemical and Biological Engineering

  2015 — 2021